Tech Company Inital Public Offerings
Ardelyx IPO
On 6/19/2014, Ardelyx became a public company.
Transaction Overview
Company Name
Announced On
6/19/2014
Transaction Type
IPO
Amount
$60,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
34175 Ardenwood Blvd. 200
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Overview
Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Raab
Chief Financial Officer
Mark Kaufmann
VP - Bus. Development
David Rosenbaum
VP - Operations
Jeffrey Jacobs
Browse more venture capital transactions:
Prev: 6/19/2014: Seventh Sense Biosystems venture capital transaction
Next: 6/19/2014: Lakewood-Amedex venture capital transaction
Share this article
About Our VC Transactions Data
We record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs